MNKD: Recently re-filed their Afrezza (inhaled insulin) NDA. Anyone here care to handicap their chances of: - Getting FDA approval on Afrezza by the end of the year. - Signing a deal on Afrezza before FDA review (they need money) - Whether Afrezza, if approved, will go the way of Exubera (pulled from market by Pfizer after marketing failure) No position, but taking a closer look. TIA